AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023 Market News
LUPKYNIS® Achieved Significantly Higher Renal Response in Lupus Nephritis Patients with High Proteinuria Compared to Patients Treated with MMF and Low Dose Steroids Alone Life Science Investing
COMPASS Pathways' Co-Founder Ekaterina Malievskaia to Step Down as Chief Innovation Officer Psychedelics Investing
OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease Pharmaceutical Investing
Komo Plant Based Foods Inc. Announces Expanded Distribution Through Koyo Foods Inc. Biotech Investing
C4 Therapeutics and Betta Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization in Greater China of CFT8919, an Orally Bioavailable BiDAC Degrader of EGFR L858R for NSCLC Life Science Investing
Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement Awards for Newly Hired Employees Life Science Investing
Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO 2023 Psychedelics Investing
BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp. Pharmaceutical Investing
